Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106957251B reveals iron-catalyzed route for alkylthiomethyl esters. Offers mild conditions and supply chain stability for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed route for thiochromene derivatives offering significant cost reduction and enhanced supply chain reliability for fine chemical manufacturing partners.
Patent CN114920707B reveals a novel iodine-promoted synthesis of 3-trifluoromethyl-1,2,4-triazoles using DMF as a dual solvent and carbon source, offering significant cost reduction in API manufacturing.
Patent CN115260080B details a novel Pd-catalyzed carbonylation route. Offers significant cost reduction and supply chain reliability for high-purity API intermediate manufacturing.
Novel C-H activation method for 2-(3-isoquinolyl)-propionic acid esters. Efficient, mild conditions, high atom economy for API manufacturing.
Patent CN107954821A reveals ruthenium catalyzed synthesis for high-purity naphthalene derivatives offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel chiral phosphoric acid catalyzed synthesis offers high optical purity and mild conditions for scalable pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN115353511A details a novel Pd-catalyzed multi-component synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable routes.
Novel synthesis of axial chiral arylindole compounds via chiral phosphoric acid. High optical purity for pharmaceutical intermediates manufacturing.
Patent CN116813544B reveals metal-free heating-promoted synthesis reducing cost and complexity for high-purity pharmaceutical intermediates supply chain reliability.
Efficient cobalt-catalyzed C-H activation for indole carboxamides. Reduces cost and improves supply chain reliability for pharma intermediates.
Novel Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles offers high efficiency and substrate compatibility, enabling cost-effective API intermediate manufacturing.
Patent CN115246757B reveals a novel Pd-catalyzed aminocarbonylation route for aryl acetamides. This method offers significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel synthesis route for high-purity dibenzo oxepin intermediates offering cost reduction and supply reliability for pharmaceutical manufacturing processes.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offers cost-effective and scalable pharmaceutical intermediate production solutions.
Novel palladacycle catalyst enables high-yield aryl nitrile synthesis using safe potassium ferrocyanide, offering cost-effective pharma intermediate solutions.
Novel heating-promoted synthesis method for 2-trifluoromethyl quinoline intermediates. Metal-free process ensures cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113735778B reveals efficient silver oxide promoted synthesis. Enables cost reduction and scalable supply chain for high purity pharmaceutical intermediates globally.
Patent CN113636968B details a Ru-catalyzed transfer hydrogenation route for 3-acylpyrroles, offering high atom economy and simplified purification for API intermediates.
Novel Pd-catalyzed carbonylation for quinoline-4(1H)-one. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.